Interpretation of 2019 How to Diagnose Heart Failure with Preserved Ejection Fraction from the Heart Failure Association of the European Society of Cardiology

doi:10.12114/j.issn.1007-9572.2020.00.155

Abstract

Abstract: Currently，heart failure with preserved ejection fraction （HFpEF） accounts for more than 50% of HF cases，but there is lack of available effective drug therapy to improve the prognosis.In 2019，the Heart Failure Association （HFA） of the European Society of Cardiology （ESC） developed a new consensus recommendation，4-step HFA-PEFF diagnostic algorithm:the first step is ＂pre-test assessment＂，and the second step is ＂echocardiographic and natriuretic peptide heart failure with preserved ejection fraction diagnostic score＂，the third step ＂functional testing＂，the fourth step ＂final aetiology＂.In this paper，not only the four-step diagnosis method is introduced in detail，but the comorbidity of HFpEF and community-based management of HF is also discussed.

Key words: Heart failure, Heart failure with preserved ejection fraction, Diagnose, Comorbidity, Community management

摘要： 目前射血分数保留的心力衰竭（HFpEF）占心力衰竭患者50%以上，并且缺乏有效改善预后的药物疗法。2019年欧洲心力衰竭协会（HFA）和欧洲心脏病学会（ESC）制定了新的专家共识——4步HFA-PEFF诊断算法，包括第一步“初始评估”，第二步“基于超声心动图和脑钠肽”，第三步“功能评估”，第四步“病因诊断”。本文在对4步诊断法详细介绍的同时，也对HFpEF的合并症以及心力衰竭的社区管理进行论述。

关键词: 心力衰竭, 射血分数保留的心力衰竭, 诊断, 合并症, 社区管理

XU Dingli,ZHANG Hao. Interpretation of 2019 How to Diagnose Heart Failure with Preserved Ejection Fraction from the Heart Failure Association of the European Society of Cardiology　[J]. Chinese General Practice, 2020, 23(11): 1327-1332. DOI: 10.12114/j.issn.1007-9572.2020.00.155.
许顶立,张昊. 2019年欧洲心力衰竭协会/欧洲心脏病学会《射血分数保留的心力衰竭的诊断》解读[J]. 中国全科医学, 2020, 23(11): 1327-1332. DOI: 10.12114/j.issn.1007-9572.2020.00.155.

References

［1］金雪娟，周京敏，葛均波.心力衰竭流行病学的研究进展［J］．中国临床医学，2013，20（6）：852-855.
JIN X J，ZHOU J M，GE J B.Progress in heart failure epidemiology［J］．Chinese Journal of Clinical Medicine，2013，20（6）：852-855.
［2］周浩斌，安冬琪，詹琼，等．不同射血分数心力衰竭患者临床特征和预后的回顾性分析［J］．中华内科杂志，2017，56（4）：253-257．DOI：10.3760/cma.j.issn.0578-1426.2017.04.003.
ZHOU H B，AN D Q，ZHAN Q，et al．A retrospective analysis of clinical characteristics and outcomes of heart failure patients with different left ventricular ejection fractions［J］．Chinese Journal of Internal Medicine，2017，56（4）：253-257．DOI：10.3760/cma.j.issn.0578-1426.2017.04.003.
［3］PONIKOWSKI P，VOORS A A，ANKER S D，et al．2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure：the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology （ESC）.Developed with the special contribution of the Heart Failure Association （HFA） of the ESC［J］．Eur J Heart Fail，2016，18（8）：891-975．DOI：10.1002/ejhf.592.
［4］PIESKE B，TSCH?PE C，DE BOER R A，et al．How to diagnose heart failure with preserved ejection fraction：the HFA-PEFF diagnostic algorithm：a consensus recommendation from the Heart Failure Association （HFA） of the European Society of Cardiology （ESC）［J］．Eur Heart J，2019，40（40）：3297-3317．DOI：10.1093/eurheartj/ehz641.
［5］OPDAHL A，REMME E W，HELLE-VALLE T，et al．Determinants of left ventricular early-diastolic lengthening velocity：independent contributions from left ventricular relaxation，restoring forces，and lengthening load［J］．Circulation，2009，119（19）：2578-2586．DOI：10.1161/CIRCULATIONAHA.108.791681.
［6］DONAL E，GALLI E，FRASER A G.Non-invasive estimation of left heart filling pressures：another nail in the coffin for E/E'?［J］．Eur J Heart Fail，2017，19（12）：1661-1663．DOI：10.1002/ejhf.944.
［7］NAGUEH S F，SMISETH O A，APPLETON C P，et al．Recommendations for the evaluation of left ventricular diastolic function by echocardiography：an update from the American Society of Echocardiography and the European Association of Cardiovascular imaging［J］．Eur Heart J Cardiovasc Imaging，2016，17（12）：1321-1360．DOI：10.1093/ehjci/jew082.
［8］GORTER T M，VAN VELDHUISEN D J，BAUERSACHS J，et al．
Right heart dysfunction and failure in heart failure with preserved ejection fraction：mechanisms and management.Position statement on behalf of the Heart Failure Association of the European Society of Cardiology［J］．Eur J Heart Fail，2018，20（1）：16-37．DOI：10.1002/ejhf.1029.
［9］SHAH A M，CLAGGETT B，SWEITZER N K，et al．Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone［J］．Circulation，2015，132（5）：402-414．DOI：10.1161/CIRCULATIONAHA.115.015884.
［10］REDDY Y N V，CARTER R E，OBOKATA M，et al．A simple，evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction［J］．Circulation，2018，138（9）：861-870．DOI：10.1161/CIRCULATIONAHA.118.034646.
［11］PRITCHETT A M，MAHONEY D W，JACOBSEN S J，et al．Diastolic dysfunction and left atrial volume：a population-based study［J］．J Am Coll Cardiol，2005，45（1）：87-92．DOI：10.1016/j.jacc.2004.09.054.
［12］OBOKATA M，KANE G C，REDDY Y N，et al．Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction：a simultaneous invasive-echocardiographic study［J］．Circulation，2017，135（9）：825-838．DOI：10.1161/CIRCULATIONAHA.116.024822.
［13］MAEDER M T，THOMPSON B R，BRUNNER-LA ROCCA H P，et al．Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction［J］．J Am Coll Cardiol，2010，56（11）：855-863．DOI：10.1016/j.jacc.2010.04.040.
［14］KITZMAN D W，HIGGINBOTHAM M B，COBB F R，et al．Exercise intolerance in patients with heart failure and preserved left ventricular systolic function：failure of the Frank-Starling mechanism［J］．J Am Coll Cardiol，1991，17（5）：1065-1072．DOI：10.1016/0735-1097（91）90832-t.
［15］TADIC M，CUSPIDI C.Obesity and heart failure with preserved ejection fraction：a paradox or something else?［J］．Heart Fail Rev，2019，24（3）：379-385．DOI：10.1007/s10741-018-09766-x.
［16］CUSPIDI C，RESCALDANI M，TADIC M，et al．Effects of bariatric surgery on cardiac structure and function：a systematic review and meta-analysis［J］．Am J Hypertens，2014，27（2）：146-156．DOI：10.1093/ajh/hpt215.
［17］SIMONENKO M.Obesity paradox in heart failure：a matter of debate［J］．Eur J Prev Cardiol，2019，26（16）：1748-1750．DOI：10.1177/2047487319861473.
［18］MCHUGH K，DEVORE A D，WU J J，et al．Heart failure with preserved ejection fraction and diabetes：JACC state-of-the-art review［J］．J Am Coll Cardiol，2019，73（5）：602-611．DOI：10.1016/j.jacc.2018.11.033.
［19］KITZMAN D W，BRUBAKER P，MORGAN T，et al．Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction：a randomized clinical trial［J］．JAMA，2016，315（1）：36-46．DOI：10.1001/jama.2015.17346.
［20］ANGADI S S，MOOKADAM F，LEE C D，et al．High-intensity interval training vs.moderate-intensity continuous exercise training in heart failure with preserved ejection fraction：a pilot study［J］．J Appl Physiol，2015，119（6）：753-758．DOI：10.1152/japplphysiol.00518.2014.
［21］LEGGIO M，FUSCO A，LORETI C，et al．Effects of exercise training in heart failure with preserved ejection fraction：an updated systematic literature review［J］．Heart Fail Rev，2019．DOI：10.1007/s10741-019-09841-x.
［22］刘翀，韦铁民，吕玲春，等．社区化管理模式在慢性左室射血分数下降的心力衰竭患者出院后随访管理中的应用价值［J］．中国慢性病预防与控制，2016，24（12）：885-889．DOI：10.16386/j.cjpccd.issn.1004-6194.2016.12.002.http://www.cnki.com.cn/Article/CJFDTotal-ZMXB201612002.htm.
［23］单红，彭翔，彭建强，等．慢性心力衰竭现代疾病管理模式的研究及进展［J］．中国全科医学，2014，17（10）：1194-1196．DOI：10.3969/j.issn.1007-9572.2014.10.031.
SHAN H，PENG X，PENG J Q，et al．Recent advances in chronic heart failure disease management models［J］．Chinese General Practice，2014，17（10）：1194-1196．DOI：10.3969/j.issn.1007-9572.2014.10.031.
［24］韩云，张季元，梁超，等．医院-社区服务中心-患者-微信一体化慢病管理模式的构建研究［J］．中国全科医学，2017，20（S3）：460-462.
HAN Y，ZHANG J Y，LIANG C，et al．Construction of hospital-community service center-patient-WeChat integrated chronic disease managemtn mode［J］．Chinese General Practice，2017，20（S3）：460-462.
［25］孙云，万进东，王丹，等．慢性病轨迹模式对射血分数保留型心力衰竭患者预后的影响［J］．中国心血管病研究，2019，17（8）：704-708.http://www.xxgzz.com.cn/ch/reader/view_abstract.aspx?file_no=201904070&flag=1.

[1]	ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129.
[2]	MA Yanyan, REN Fuxian, WANG Yu, GAO Dengfeng. The Prediction Value of (Neutrophil+Monocyte) /Lymphocyte Ratio on In-hospital Mortality of Heart Failure Patients [J]. Chinese General Practice, 2023, 26(30): 3791-3796.
[3]	ZHANG Zhendong, CAI Bin, WANG Hongwei, QIAO Zengyong. Study on the Changes of Intestinal Flora and Its Metabolite Phenylacetylglutamine in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(29): 3665-3673.
[4]	HE Li, ZHANG Yifan, SHEN Xuechun, SUN Yan, ZHAO Yang. Prevalence Trends of Multimorbidity among Residents in Mainland China: a Meta-analysis [J]. Chinese General Practice, 2023, 26(29): 3599-3607.
[5]	PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615.
[6]	WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627.
[7]	FEI Sijie, ZHANG Qiang, LIU Fangfang, BAI Lu, SUN Caihong, XIN Caifeng. Correlation between Glycated Hemoglobin Variability and New-onset Atrial Fibrillation in Type 2 Diabetes Patients Combined with Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2023, 26(26): 3246-3251.
[8]	ZHENG Xiao, TIAN Feng, CHEN Yiming, XUE Benli, SHI Lei, ZHANG Chichen. Research Hotspots and Evolutionary Trends on Multimorbidity in China from 2002 to 2022 [J]. Chinese General Practice, 2023, 26(21): 2567-2573.
[9]	FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580.
[10]	CHEN Ruimin, LIU Fang, TAN Hong, HAN Shufang, CHEN Yingjian, SU Congcong. Effects of Dapagliflozin on the Expression of MicroRNA-423-5p and Cardiac Function in Patients with Type 2 Diabetes Mellitus and Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(14): 1733-1738.
[11]	HU Huachao, CHEN Xianya, XIE Siyuan, XIA Zhen, XIAO Hua. Clinical Characteristics and Treatment of Atrial Fibrillation and Heart Failure: a Multicenter Survey [J]. Chinese General Practice, 2023, 26(05): 541-549.
[12]	CHEN Ying, ZHENG Hui, HE Yu. Association between Nutritional Status and Prognosis in Elderly Patients with Heart Failure with Preserved Ejection Fraction and Coronary Heart Diseases [J]. Chinese General Practice, 2023, 26(03): 335-342.
[13]	GAO Yan, LIANG Kun, LUAN Mingya, ZHANG Jianxin, XU Ning, LIU Nana, ZHANG Xiaoping, SHANG Gechu, LIU Kewei. Effect of Two Commonly Used Doses of Tolvaptan on the Prognosis of Elderly Patients with Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(02): 233-240.
[14]	HAN Tao, SUN Kai, SUN Chuanrui, ZHANG Yili, XIE Yanming, SHEN Hao, WANG Xu, QI Baoyu, ZHU Liguo, WEI Xu. Prevalence and Associated Factors of Lumbar Disc Herniation in Osteoporosis: a Cross-sectional Survey [J]. Chinese General Practice, 2022, 25(35): 4375-4380,F01.
[15]	WEI Xu, LIU Ning, ZHANG Yili, HAN Tao, SUN Kai, QI Baoyu, CHEN Xin, QIN Xiaokuan, GAO Jinghua, XIE Yanming, ZHU Liguo. Comorbidities of Osteoporosis: Recent Advances and Early Screening [J]. Chinese General Practice, 2022, 25(35): 4369-4374.